Study: Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease.
Phase II
· Site: 713 (USA) (Dr. Kowalski)
· consented 2014-01-19
Adverse events
4
Serious AEs
0
Open data queries
0
Luna dropout signal
–
Adverse events
moderate
assessed
2026-08-18
Moderate APPLICATION SITE IRRITATION — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-03-19 (study day 60.0); relationship: PROBABLE
moderate
assessed
2026-08-18
Moderate APPLICATION SITE IRRITATION — outcome: RECOVERED/RESOLVED; onset 2014-03-19 (study day 60.0); relationship: PROBABLE
mild
assessed
2026-08-18
Mild NAUSEA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-03-27 (study day 68.0); relationship: POSSIBLE
mild
assessed
2026-08-18
Mild NAUSEA — outcome: RECOVERED/RESOLVED; onset 2014-03-27 (study day 68.0); relationship: POSSIBLE
Data queries
No data queries.
☾ Luna engagement
This participant doesn't use Luna.